Paid Clinical Trials for Prostate Cancer

Showing 1 – 20 of 220 results

Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

by CTG

in Prostate Cancer, Magnetic Resonance Imaging, Population at Risk

Other

New York

Deadline:

10/31/2028

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

by CTG

in Prostate Cancer

Other

Maryland

Deadline:

11/30/2029

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

by CTG

in Prostate Cancer

Other

Alaska

Deadline:

07/31/2029

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

by CTG

in Prostate Cancer

Other

Illinois

Deadline:

11/01/2029

Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

by CTG

in Breast Cancer, Prostate Cancer, Cancer-related Fatigue

Other

Colorado

Deadline:

12/01/2030

Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer

by CTG

in Prostate Cancer

Other

New York

Deadline:

02/21/2026

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

by CTG

in Prostate Cancer

Other

Colorado

Deadline:

12/01/2026

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

by CTG

in Breast Cancer, Prostate Cancer

Other

Oklahoma

Deadline:

10/01/2030

Clinical Trial of Approaches to Prostate Cancer Surgery

by CTG

in Prostate Cancer

Other

District of Columbia

Deadline:

12/01/2026

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

by CTG

in Prostate Cancer, Prostate CA, Prostate Cancer (Adenocarcinoma), Prostate Cancer (Post Prostatectomy), Prostate Cancers

Other

Illinois

Deadline:

05/04/2027

T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer

by CTG

in Prostate Cancer

Other

Georgia

Deadline:

08/01/2026

Circulating Tumor DNA in High Risk Localized Prostate Cancer

by CTG

in Prostate Cancer

Other

Pennsylvania

Deadline:

09/30/2027

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

by CTG

in Prostate Cancer

Other

Texas

Deadline:

12/01/2028

Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

by CTG

in Prostate Cancer

Other

New York

Deadline:

12/31/2040

Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

by CTG

in Prostate Cancer

Other

California

Deadline:

12/01/2028

Telmisartan in Prostate Cancer

by CTG

in Prostate Cancer

Other

New Hampshire

Deadline:

04/01/2027

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

by CTG

in Prostate Cancer, Esophageal Cancer, Lung Cancer (NSCLC), Solid Tumor Malignancies

Other

Florida

Deadline:

09/15/2027

Improving Health Literacy in African-American Prostate Cancer Patients

by CTG

in Prostate Cancer

Other

Georgia

Deadline:

03/31/2027

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

by CTG

in Prostate Cancer

Other

Maryland

Deadline:

03/07/2027

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

by CTG

in Prostate Cancer

Other

California

Deadline:

03/21/2032

Load more All clinical trials loaded.

Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

Clinical Trial of Approaches to Prostate Cancer Surgery

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer

Circulating Tumor DNA in High Risk Localized Prostate Cancer

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

Telmisartan in Prostate Cancer

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Improving Health Literacy in African-American Prostate Cancer Patients

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Prostate Cancer

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps